相似文献/References:
[1]何常楠,傅鸿鹏.20种基本药物的集中采购价格分析[J].卫生经济研究,2016,(08):44.
[2]赵 静.应用层次分析法优化基本药物遴选的研究[J].卫生经济研究,2016,(12):13.
[3]王文杰,毛宗福,肖琳琪,等.贫困地区基层医疗机构基本药物供应保障研究[J].卫生经济研究,2018,(02):35.
[4]裴 婕,路 云,周 萍,等.瑞典基本药物目录的发展及启示[J].卫生经济研究,2018,(08):46.
PEI Jie,LU Yun,ZHOU Ping,et al.The development and enlightenment of essential drug list in Sweden[J].Journal Press of Health Economics Research,2018,(08):46.
[5]杜雯雯,徐 伟,李孟林.南京市各级医疗机构用药结构和用药衔接性研究[J].卫生经济研究,2018,(09):26.
DU Wen-wen,XU Wei,LI Meng-lin.Study on the Structure and Coherence of Drug Use in Medical Institutions at All Levels in Nanjing[J].Journal Press of Health Economics Research,2018,(08):26.
[6]吴玉霞,徐 伟,蔡功杰,等.基本药物可获得性影响因素研究——基于25省监测点数据的实证分析[J].卫生经济研究,2018,(12):37.
WU Yu-xia,XU Wei,CAI Gong-jie,et al.Study on the Factors Affecting the Availability of Essential Drugs——An Empirical Analysis Based on Data from 25 Provinces[J].Journal Press of Health Economics Research,2018,(08):37.
[7]杜雯雯,徐 伟,蔡功杰.我国基本药物全额保障的实现路径研究[J].卫生经济研究,2018,(12):40.
DU Wen-wen,XU Wei,CAI Gong-jie.Study on the Realizing Path of the Full Guarantee of Essential Medicines in China[J].Journal Press of Health Economics Research,2018,(08):40.
[8]尚兰成,常 峰,路 云.药价改革后我国药品价格形势分析——基于我国省际面板数据的实证研究[J].卫生经济研究,2019,(04):59.
SHANG Lan-cheng,CHANG Feng,LU Yun.Analysis of China's Drug Price Situation after Drug Price Reform——An Empirical Study Based on Provincial Panel Data in China[J].Journal Press of Health Economics Research,2019,(08):59.
[9]张闪闪,吴 天,张 冉,等.2018年版《国家基本药物目录》调整解读[J].卫生经济研究,2019,(06):47.
ZHANG Shan-shan,WU Tian,ZHANG Ran,et al.Interpretation of the 2018 Edition of the National Essential Drugs List[J].Journal Press of Health Economics Research,2019,(08):47.
[10]张迎春,丁俊杰,马光辉.考虑货币购买力的省域综合医疗服务价格差异分析[J].卫生经济研究,2021,38(8):66.
ZHANG Ying-chun,DING Jun-jie,MA Guang-hui.Analysis on Price Differences of Provincial Comprehensive Medical Services Based on Purchasing Power of Money[J].Journal Press of Health Economics Research,2021,38(08):66.